1-20 of 20
Authors: Yalan Zhang
Save search
Sort by
Journal Article

Genomic evidence for hybridization and introgression between blue peafowl and endangered green peafowl and molecular foundation of leucistic plumage of blue peafowl Open Access

PDF
Gang Wang and others
GigaScience, Volume 14, 2025, giae124, https://doi.org/10.1093/gigascience/giae124
Published: 19 February 2025
Journal Article

PATH-40. “DE NOVO REPLICATION REPAIR DEFICIENT GLIOBLASTOMA, IDH-WILDTYPE” IS A DISTINCT GLIOBLASTOMA SUBTYPE IN ADULTS THAT MAY BENEFIT FROM IMMUNE CHECKPOINT BLOCKADE Free

PDF
Sara Hadad and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v177, https://doi.org/10.1093/neuonc/noad179.0670
Published: 10 November 2023
Journal Article

PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma Free

PDF
Sabine Mueller and others
Neuro-Oncology, Volume 25, Issue 11, November 2023, Pages 2074–2086, https://doi.org/10.1093/neuonc/noad105
Published: 15 June 2023
Journal Article

SURG-19. PROGNOSTIC VALIDATION OF A NEW CLASSIFICATION SYSTEM FOR EXTENT OF RESECTION IN GLIOBLASTOMA: A REPORT OF THE RANO RESECT GROUP Free

PDF
Philipp Karschnia and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii255, https://doi.org/10.1093/neuonc/noac209.985
Published: 14 November 2022
Journal Article

CTNI-09. DIFFUSE MIDLINE GLIOMA-ADAPTIVE COMBINATORY TRIAL (DMG-ACT): A COMBINATION PLATFORM TRIAL IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH DIFFUSE MIDLINE GLIOMA Free

PDF
Andrea Franson and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii71–vii72, https://doi.org/10.1093/neuonc/noac209.275
Published: 14 November 2022
Journal Article

TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO resect group Open Access

PDF
Philipp Karschnia and others
Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac158, https://doi.org/10.1093/noajnl/vdac158
Published: 29 September 2022
Journal Article

Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group Open Access

PDF
Philipp Karschnia and others
Neuro-Oncology, Volume 25, Issue 5, May 2023, Pages 940–954, https://doi.org/10.1093/neuonc/noac193
Published: 12 August 2022
Journal Article

DIPG-31. Prognostic and predictive biomarkers of response in children and young adults with H3K27M-altered diffuse intrinsic pontine glioma: results from a multi-center, interventional clinical trial (PNOC003) Open Access

PDF
Cassie Kline and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i25, https://doi.org/10.1093/neuonc/noac079.088
Published: 03 June 2022
Journal Article

DIPG-09. Diffuse Midline Glioma-Adaptive Combinatory Trial (DMG-ACT): A biology-driven platform trial in pediatric and young adult patients with diffuse midline glioma Open Access

PDF
Andrea Franson and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i19, https://doi.org/10.1093/neuonc/noac079.066
Published: 03 June 2022
Journal Article

Prospective genomically guided identification of “early/evolving” and “undersampled” IDH-wildtype glioblastoma leads to improved clinical outcomes Open Access

PDF
Yalan Zhang and others
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1749–1762, https://doi.org/10.1093/neuonc/noac089
Published: 08 April 2022
Journal Article

PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications Free

PDF
Esraa Mohamed and others
Neuro-Oncology, Volume 24, Issue 9, September 2022, Pages 1471–1481, https://doi.org/10.1093/neuonc/noac064
Published: 14 March 2022
Journal Article

Categorizing continuous biomarkers: More cons than pros Free

PDF
Yalan Zhang and Annette M Molinaro
Neuro-Oncology Practice, Volume 9, Issue 2, April 2022, Pages 81–82, https://doi.org/10.1093/nop/npac012
Published: 17 February 2022
Journal Article

PATH-30. CLINICAL AND GENETIC CHARACTERISTICS OF HISTONE H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMAS IN ADULTS Free

PDF
Jessica Schulte and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii170–ii171, https://doi.org/10.1093/neuonc/noaa215.711
Published: 09 November 2020
Journal Article

SURG-15. A NOVEL RISK MODEL TO DEFINE THE RELATIVE BENEFIT OF MAXIMAL EXTENT OF RESECTION WITHIN PROGNOSTIC GROUPS IN NEWLY DIAGNOSED DIFFUSE LOW-GRADE GLIOMA Free

PDF
Shawn Hervey-Jumper and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii206, https://doi.org/10.1093/neuonc/noaa215.862
Published: 09 November 2020
Journal Article

SURG-18. THE IMPACT OF NEUROLOGIC IMPAIRMENTS ON THE RELATIVE BENEFIT OF MAXIMAL EXTENT OF RESECTION IN NEWLY DIAGNOSED IDH-WILD TYPE GLIOBLASTOMA Free

PDF
Shawn Hervey-Jumper and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii207, https://doi.org/10.1093/neuonc/noaa215.865
Published: 09 November 2020
Journal Article

Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults Open Access

PDF
Jessica D Schulte and others
Neuro-Oncology Advances, Volume 2, Issue 1, January-December 2020, vdaa142, https://doi.org/10.1093/noajnl/vdaa142
Published: 22 October 2020
Journal Article

MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence Free

PDF
Radhika Mathur and others
Neuro-Oncology, Volume 22, Issue 11, November 2020, Pages 1580–1590, https://doi.org/10.1093/neuonc/noaa059
Published: 13 March 2020
Journal Article

GENE-35. MGMT PROMOTER METHYLATION IN NEWLY DIAGNOSED LGG AS A POTENTIAL BIOMARKER FOR TMZ-ASSOCIATED HYPERMUTATION AT RECURRENCE Free

PDF
Radhika Mathur and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi105, https://doi.org/10.1093/neuonc/noz175.437
Published: 11 November 2019
Journal Article

RTHP-33. A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS ON SURVIVAL BASED ON TREATMENT PARADIGMS FOR PATIENTS WITH ANAPLASTIC OLIGODENDROGLIOMA Free

PDF
Jacob Young and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi216–vi217, https://doi.org/10.1093/neuonc/noz175.904
Published: 11 November 2019
Journal Article

PATH-05. IMPLEMENTATION OF A TARGETED NEXT-GENERATION SEQUENCING PANEL FOR THE DIAGNOSIS AND PRECISION MEDICINE TREATMENT OF ADULT PATIENTS WITH WHO GRADE IV DIFFUSE GLIOMAS Free

PDF
Yalan Zhang and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi158–vi159, https://doi.org/10.1093/neuonc/noy148.661
Published: 05 November 2018